Q2
ACHV — Q2 2026 Financial Report Analysis
Achieve's Q2 net loss swelled to $74.8M on $57.5M of non-cash warrant charges after an FDA rejection tied to a contract manufacturer, while a $168M April raise left $187.3M in cash for a Q4 2026 resubmission.